Women and CBD: Increased Interest, but Caution Is Warranted
Drug Topics
SEPTEMBER 13, 2022
CBD can be used to treat a myriad of women’s health conditions, but research is still limited.
Sat.Sep 10, 2022 - Fri.Sep 16, 2022
581 
New data: The 340B program is driving up costs for patients and our health care system
PhRMA
SEPTEMBER 16, 2022
Guess what? The 340B program grew, yet again, hitting a whopping $43.9 billion in sales at the discounted 340B price in 2021. But there has not been evidence of corresponding growth in care provided to vulnerable patients at 340B covered entities. And making matters worse, fresh data show that 340B may actually be driving up costs for some patients and our health care system as whole.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Red Jacket: Fabio Gratton
PharmaVoice
SEPTEMBER 16, 2022
The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.
Study: Anti-Depressants May Help Avoid Severe COVID-19 Symptoms
Pharmacy Times
SEPTEMBER 12, 2022
Although serotonin is widely associated with feelings of happiness, a study suggests it may be associated with the severity of COVID-19.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Mitigating Costs of Cancer Treatment: The Role of Pharmacists
Drug Topics
SEPTEMBER 12, 2022
Cancer care is expensive, but pharmacists can help.
Timely reauthorization of PDUFA and BsUFA is vital to the FDA’s review of medicines
PhRMA
SEPTEMBER 12, 2022
As we’ve discussed on this blog before, timely reauthorization of the Prescription Drug User Fee Act (PDUFA) and the Biosimilar User Fee Act (BsUFA) is critical to sustaining the U.S. Food and Drug Administration’s (FDA) ability to keep pace with the number of innovative drugs, biologics and biosimilars entering the regulatory review pipeline.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
STAT+: USDA starts cracking down on companies that ship animals without timely inspections
STAT
SEPTEMBER 10, 2022
Earlier this year, a leading animal rights group asked U.S. authorities to investigate medical research labs for allegedly violating federal law after finding numerous instances where nearly 2,000 monkeys were shipped between facilities without required veterinary inspections. Now, the federal government appears to be acting.
The Evolution of the CBD Regulatory Landscape
Drug Topics
SEPTEMBER 14, 2022
No federal agency has taken charge of regulating cannabidiol products, leaving decisions up to the individual states.
Navigating the patient experience: Burdens and barriers standing between patients and their care
PhRMA
SEPTEMBER 12, 2022
Health care affordability is not the only hurdle facing patients, according to PhRMA’s third Patient Experience Survey (PES). The latest PES report exposes another crucial problem: the frustration and confusion people have around how to use their coverage. Administrative hurdles and other barriers imposed by health insurers and pharmacy benefit managers (PBMs), such as time-consuming paperwork or prior authorization, are a challenge for many insured Americans, including more vulnerable communiti
Methadone at home? Emerging tech provides new tool in the fight against opioid addiction
PharmaVoice
SEPTEMBER 15, 2022
Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Akero treatment for NASH reduces liver scarring, achieves goals of mid-stage study
STAT
SEPTEMBER 13, 2022
Akero Therapeutics said Tuesday that an experimental medicine improved liver scarring at twice the rate of a placebo without worsening other symptoms — achieving the main goal of a mid-stage clinical trial involving patients with the fatty liver disease known as NASH. If the encouraging study results are confirmed in later Phase 3 clinical trials, the Akero drug, called efruxifermin, could become an effective treatment for a chronic disease that has grown into one of the leading causes of
How to Increase CBD Sales at Your Independent Pharmacy
Drug Topics
SEPTEMBER 10, 2022
Tips to help your pharmacy stand out as a knowledgeable CBD retailer.
The Impact of Prior Authorization on Patients With Cancer
Pharmacy Times
SEPTEMBER 16, 2022
Prior authorizations have delayed time to treatment for patients and can directly impact clinical outcomes.
Red Jacket: Jim Lang
PharmaVoice
SEPTEMBER 16, 2022
The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
With increased virus activity, providers urged to be alert for signs of rare polio-like syndrome in kids
STAT
SEPTEMBER 12, 2022
Pediatricians and top health officials are warning about an uptick in activity of a common virus that in rare cases can cause a polio-like syndrome in young children. The virus, an enterovirus known as EV-D68, is one of the bugs that regularly circulates and infects us from time to time, typically just causing colds. But occasionally, children infected with it will develop limb weakness and a progressive form of paralysis, what’s called acute flaccid myelitis , or AFM.
Tips for Managing Diabetes Comorbidities
Drug Topics
SEPTEMBER 14, 2022
Considering comorbidities is just as important as lowering patient HbA1c.
How convenient health clinics are continuing the growth of retail health care
Drug Store News
SEPTEMBER 13, 2022
Convenient care clinics continue to expand their offerings and their appeal to consumers.
Woman of the Week: Agilent Technologies’ Dr. Katharine Knobil
PharmaVoice
SEPTEMBER 14, 2022
As the first chief medical officer of the diagnostic testing company, Dr. Katharine Knobil is focused on moving the science forward beyond precision oncology to liquid biopsy.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease
STAT
SEPTEMBER 16, 2022
Intellia Therapeutics said Friday the first six patients to receive its CRISPR-based treatment for a genetic swelling disorder have safely had small, corrective changes made to dysfunctional DNA inside their liver cells. Preliminary results from the study — just the second to show that CRISPR-based gene editing can be delivered systemically and performed in vivo, or inside the body — found that the treatment, NTLA-2002, reduced levels of the disease-causing protein, kallikrein, by
Babies Given Antibiotics May Have Adult GI issues
Drug Topics
SEPTEMBER 13, 2022
New research adds further evidence that early in life antibiotic exposure can have lifelong impact.
Long-Term Impact of C. difficile Infection (CDI) and Infection Recurrence
Pharmacy Times
SEPTEMBER 14, 2022
A gastroenterologist reviews the long-term impact of dysbiosis and Clostridioides difficile infection.
Medication affordability’s impact on adherence and outcomes
PharmaVoice
SEPTEMBER 12, 2022
Improved patient affordability is an important lever that can increase adherence, which in turn can improve health outcomes.
Opinion: 6 tactics to make artificial intelligence work on the frontlines
STAT
SEPTEMBER 15, 2022
Artificial intelligence is a transformative tool in the workplace — except when it isn’t. For top managers, state-of-the art AI tools are a no-brainer: in theory, they increase revenues, decrease costs, and improve the quality of products and services. But in the wild, it’s often just the opposite for frontline employees who actually need to integrate these tools into their daily work.
Potential Impact of Inflation Reduction Act on Biosimilars
Drug Topics
SEPTEMBER 13, 2022
Several provisions in the law are designed to protect and foster the biosimilar market. But some representatives of the sector see CMS drug price negotiation as a threat to profit margins.
Novo Nordisk partners with Microsoft for AI-driven drug discovery
Pharmaceutical Technology
SEPTEMBER 13, 2022
Novo Nordisk has signed a new strategic partnership with Microsoft to expedite the discovery and development of drugs leveraging big data and artificial intelligence (AI). Under the deal, Microsoft's computational services, Cloud and artificial intelligence (AI) will be merged with the drug discovery, development and data science expertise of Novo Nordisk.
The 2022 Red Jacket honorees
PharmaVoice
SEPTEMBER 16, 2022
Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.
Biden appoints former government scientist as first leader of ARPA-H
STAT
SEPTEMBER 12, 2022
President Joe Biden plans to appoint longtime biologist and former government scientist Renee Wegrzyn as the first director of the nascent Advanced Research Projects Agency for Health. Biden’s announcement comes as ARPA-H advocates debate where the multibillion-dollar agency should be headquartered and which elusive disease areas should be prioritized.
Time to Glycemic Targets by 4-12 Weeks Reduced in Tirzepatide In Comparison to Other Therapies
Drug Topics
SEPTEMBER 16, 2022
New research offers evidence that tirzepatide could help patients achieve glycemic goals.
The future of AI drug discovery & development in immunology and GPCR research
pharmaphorum
SEPTEMBER 16, 2022
Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic targeting in immune-mediated disease”.
Feds could soon bring COVID-style fight to superbug threat
PharmaVoice
SEPTEMBER 13, 2022
COVID-19 has inspired renewed urgency in the need for weapons to combat antimicrobial resistant infections and new hope of government funding to meet the challenge.
STAT+: Alphabet spinout Verily raises $1 billion as it looks to harness health data
STAT
SEPTEMBER 10, 2022
Alphabet’s life sciences offshoot Verily said Friday that it has raised $1 billion to fuel its next stage of development — one that will be steered by a new corporate leader as CEO Andy Conrad plans to shift to an advisory role. The eye-popping funding round was led by Alphabet, reinforcing Verily’s ties to its corporate parent even as it seeks to assert its independence and build a profitable business after years of sometimes scattershot projects and investments.
Researchers Investigating Two Novel Diabetes Treatments
Drug Topics
SEPTEMBER 10, 2022
In the early stages of development, researchers find 2 treatments are efficacious for diabetes.
Gene Therapy Restores Some Vision in Colorblind Children
Pharmacy Times
SEPTEMBER 16, 2022
Study suggests gene therapy may effectively treat young children who were born colorblind via pathways connecting the brain and the retina.
Let's personalize your content